chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report received from a healthcare worker refers to a 33 years old patient of unknown gender. On 13-NOV-2014, patient was vaccinated with an improperly stored dose of M-M-R II (lot# J016232, Expiry: 19-DEC-2015, dose number 2) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 4 year old patient of unknown gender. On 04-NOV-2014, patient was vaccinated with an improperly stored dose of M-M-R II (lot# J016232, Expiry; 19-DEC-2015, therapy type: HSA, dose number 2) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 1.25
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 14 months old patient of unknown gender. On 29-OCT-2014, patient was vaccinated with an improperly stored dose of M-M-R II (lot# J016232, Expiry: 19-DEC-2015, dose number 2) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 1.02
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 12 months old patient of unknown gender. On 29-OCT-2014, patient was vaccinated with an improperly stored doses of MMR II (lot# J016232, Expiry: 19-DEC-2015, therapy type: HSA, dose number) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 12 months old patient of unknown gender. On 27-OCT-2014, patient was vaccinated with an improperly stored dose of M-M-R II (lot# J016232, Expiry: 19-DEC-2015, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 1.02
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 12 months old patient of unknown gender. On 21-OCT-2014, patient was vaccinated with an improperly stored dose of MMR II (lot# J016232, Expiry: 19-DEC-2015, therapy type: HSA, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 4 years old patient of unknown gender. On 14-OCT-2014, patient was vaccinated with an improperly stored dose of MMR II (lot# J016232, Expiry: 19-DEC-2015, therapy type: HSA, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 1.01
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 12 months old patient of unknown gender. On 14-OCT-2014, patient was vaccinated with an improperly stored dose of MMR II (lot# J016232, Expiry: 19-DEC-2015, therapy type: HSA, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 1.02
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 12 months old patient of unknown gender. On 13-OCT-2014, patient was vaccinated with an improperly stored dose of MMR II (lot# J016232, Expiry: 19-DEC-2015, therapy type: HSA, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 1.05
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 12 months old patient of unknown gender. On 13-OCT-2014, patient was vaccinated with an improperly stored dose of MMR II (lot# J016232, Expiry: 19-DEC-2015, therapy type: HSA, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 54.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Myalgia
Clinical narrative: Myalgia and soreness, redness, warmth, swelling left upper arm. Diphenhydramine 25 mg Qweek, prednisone 30 mg once, cephalexin 500 mg BID.
Age: 2.0
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 2 years old patient of unknown gender. On 08-OCT-2014, patient was vaccinated with an improperly stored dose of M-M-R II (lot# J016232, Expiry: 19-DEC-2015, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site swelling
Clinical narrative: Swelling 3 x 3 cm rt. thigh. Reaction to varicella shot.
Age: 1.1
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 13 months old patient of unknown gender. On 02-DEC-2014, patient was vaccinated with an improperly stored dose of MMR II (lot# J016232, Expiry: 19-DEC-2015, therapy type: HSA, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 12 months old patient of unknown gender. On 04-DEC-2014, patient was vaccinated with an improperly stored dose of M-M-R II (lot# J016232, Expiry: 19-DEC-2015, therapy type: HSA, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 1.01
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 12 months old patient of unknown gender. On 12-DEC-2014, patient was vaccinated with an improperly stored dose of MMR II (lot# J016232, Expiry: 19-DEC-2015, therapy type: HSA, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 1.37
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 16 months old patient of unknown gender. On 18-DEC-2014, patient was vaccinated with an improperly stored dose of MMR II (lot# J016232, Expiry: 19-DEC-2015, therapy type: HSA, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 3.0
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 3 years old patient of unknown gender. On 18-DEC-2014, patient was vaccinated with an improperly stored dose of MMR II (lot# J016232, Expiry: 19-DEC-2015, therapy type: HSA, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 1.02
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 12 months old patient of unknown gender. On 30-DEC-2014, patient was vaccinated with an improperly stored dose of M-M-R II (lot# J016232, Expiry: 19-DEC-2015, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: This spontaneous report was received from a consumer regarding unspecified patients who were 30-40 years old, enrolled in a market research. On an unknown date, unspecified patients was vaccinated with GARDASIL (strength, dose, frequency unknown). All the patients experienced inappropriate schedule of drug administration. Outcome of inappropriate schedule of drug administration was unknown. Reporter considered the event, inappropriate schedule of drug administration to be not related to GARDASIL. Additional information is not expected.
Age: 1.0
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 12 months old patient of unknown gender. This case was originally opened on 06-OCT-2014 to evaluate improperly stored vaccines. On 13-OCT-2014, (also reported as since the first call) patient was possibly vaccinated with an improperly stored dose of M-M-R II (lot# J016232, Expiry: 19-DEC-2015, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 1.03
Sex: U
Vaccine: MMR
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 12 months old patient of unknown gender. On 13-OCT-2014, patient was vaccinated with an improperly stored dose of M-M-R II (lot# J016232, Expiry: 19-DEC-2015, dose number 1) (dose and route was unknown). No adverse effects reported. This is one of the several reports linked with the same reporter link. No further information was available. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Erythema, Hypersensitivity, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Patient words: per MOC has a reaction to a vaccine he got 2 days ago. The patient is a 12 year, 5 month old male who presents with an allergic reaction. The child is an established patient. The patient presents with mother. Symptoms include other (localized swelling and redness). The rash is located on the arm(s). The rash is described as red, raised and swollen. Onset was 2 day(s) ago. Onset followed other (vaccine injection). Symptoms are described as worsening. The patient is not currently being treated for this problem. Note for "Allergic reaction": patient has redness, swelling and warmth on his right deltoid the area is 10.5 cm in width and 9 cm in height has progressively enlarged since he got his mining vaccine on the site 2 days ago, the reaction is localized denies any respiratory distress, no rashes, no hives, no oral swelling, or difficulty swallowing, (note; reported to VAERS System) by staff. Area is itching. No vomiting. Denies any prior reactions to any vaccines. Mom does report that patient has significant skin reactions to things like bug bites.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site warmth, Local swelling, Rash erythematous
Clinical narrative: Patient words: per MOC has a reaction to a vaccine he got 2 days ago. The patient is a 12 year, 5 month old male who presents with an allergic reaction. The child is an established patient. The patient presents with mother. Symptoms include other (localized swelling and redness). The rash is located on the arm(s). The rash is described as red, raised and swollen. Onset was 2 day(s) ago. Onset followed other (vaccine injection). Symptoms are described as worsening. The patient is not currently being treated for this problem. Note for "Allergic reaction": patient has redness, swelling and warmth on his right deltoid the area is 10.5 cm in width and 9 cm in height has progressively enlarged since he got his mining vaccine on the site 2 days ago, the reaction is localized denies any respiratory distress, no rashes, no hives, no oral swelling, or difficulty swallowing, (note; reported to VAERS System) by staff. Area is itching. No vomiting. Denies any prior reactions to any vaccines. Mom does report that patient has significant skin reactions to things like bug bites.
Age: 31.0
Sex: F
Vaccine: TDAP
Symptoms: Joint range of motion decreased, Musculoskeletal pain
Clinical narrative: Severe shoulder pain, limited range of motion lasting over 10 days.
Age: 52.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Injection site pruritus, Malaise, Pyrexia, Rash erythematous
Clinical narrative: General malaise at onset of symptoms and at 4:00 PM chills began. Full fever of 102.5 began ~4:45 PM. Took Advil for fever. Fever broke at ~4:00 AM on 01/15/2015. Incredibly sore, swollen, ichy and red rash at vaccination location (left upper arm) that began ~3 hours after vaccination. Arm is still slightly sore, itchy and a small bump is present now (01/25/2015).
Age: 52.0
Sex: F
Vaccine: PPV
Symptoms: Vaccination site pain, Vaccination site reaction, Vaccination site swelling
Clinical narrative: General malaise at onset of symptoms and at 4:00 PM chills began. Full fever of 102.5 began ~4:45 PM. Took Advil for fever. Fever broke at ~4:00 AM on 01/15/2015. Incredibly sore, swollen, ichy and red rash at vaccination location (left upper arm) that began ~3 hours after vaccination. Arm is still slightly sore, itchy and a small bump is present now (01/25/2015).
Age: 44.0
Sex: F
Vaccine: HEP
Symptoms: Asthenia, Pyrexia, Urticaria
Clinical narrative: Fever, weakness and hives on arms, thighs and legs, lasting more than a week so far.
Age: 57.0
Sex: F
Vaccine: DTAP, VARZOS
Symptoms: Cellulitis, Chills, Headache, Hypersensitivity, Injection site discolouration
Clinical narrative: Large red, swollen welt. The size was 4 inch diameter circle centering around the injection site. It was raised 1/2 cm. It became very hot and painful. By 11:00 AM on 1/23/15 a darker large spot centered around the injection site formed on top of the other one. This one was a circle 1 inch in diameter. This spot developed tiny blister-like bumps on it and appeared with a yellow tint. I stopped at my Drs office on my way to work, the nurse came and looked at it and said it was normal. I developed chills and a fever within a couple hours. I had a fever at 101.0. On Saturday 1/24 I had shaking, intense chills, headache and muscle aches through my body. At 6:00 pm I had a fever of 101.5 and the welt was just over 6 inches in diameter. I went to an urgent care and at 7:00 pm my temp was up to 102.5. They diagnosed me with an allergic reaction and cellulitis. I was given an injection of rocephin and put on a high dose of Augmentin. On 1/24/2015 at 10:30 AM, the welt had grown to over 7.25 inches in diameter and the darker red one grew to 2.5 inches in length. As of right now I am seeking additional help for symptoms.
Age: 57.0
Sex: F
Vaccine: DTAP, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site reaction, Injection site warmth, Myalgia
Clinical narrative: Large red, swollen welt. The size was 4 inch diameter circle centering around the injection site. It was raised 1/2 cm. It became very hot and painful. By 11:00 AM on 1/23/15 a darker large spot centered around the injection site formed on top of the other one. This one was a circle 1 inch in diameter. This spot developed tiny blister-like bumps on it and appeared with a yellow tint. I stopped at my Drs office on my way to work, the nurse came and looked at it and said it was normal. I developed chills and a fever within a couple hours. I had a fever at 101.0. On Saturday 1/24 I had shaking, intense chills, headache and muscle aches through my body. At 6:00 pm I had a fever of 101.5 and the welt was just over 6 inches in diameter. I went to an urgent care and at 7:00 pm my temp was up to 102.5. They diagnosed me with an allergic reaction and cellulitis. I was given an injection of rocephin and put on a high dose of Augmentin. On 1/24/2015 at 10:30 AM, the welt had grown to over 7.25 inches in diameter and the darker red one grew to 2.5 inches in length. As of right now I am seeking additional help for symptoms.
Age: 57.0
Sex: F
Vaccine: DTAP, VARZOS
Symptoms: Pyrexia, Rash vesicular, Tremor, Urticaria
Clinical narrative: Large red, swollen welt. The size was 4 inch diameter circle centering around the injection site. It was raised 1/2 cm. It became very hot and painful. By 11:00 AM on 1/23/15 a darker large spot centered around the injection site formed on top of the other one. This one was a circle 1 inch in diameter. This spot developed tiny blister-like bumps on it and appeared with a yellow tint. I stopped at my Drs office on my way to work, the nurse came and looked at it and said it was normal. I developed chills and a fever within a couple hours. I had a fever at 101.0. On Saturday 1/24 I had shaking, intense chills, headache and muscle aches through my body. At 6:00 pm I had a fever of 101.5 and the welt was just over 6 inches in diameter. I went to an urgent care and at 7:00 pm my temp was up to 102.5. They diagnosed me with an allergic reaction and cellulitis. I was given an injection of rocephin and put on a high dose of Augmentin. On 1/24/2015 at 10:30 AM, the welt had grown to over 7.25 inches in diameter and the darker red one grew to 2.5 inches in length. As of right now I am seeking additional help for symptoms.
Age: 32.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Urticaria
Clinical narrative: Hives/urticaria (small welts/skin wheals) appear at random parts of the body. Slowly spread apart throughout the day, then disappear. Skin welts can be aggravated with physical contact and grow larger.
Age: 32.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Blood test, Urticaria
Clinical narrative: Hives/urticaria (small welts/skin wheals) appear at random parts of the body. Slowly spread apart throughout the day, then disappear. Skin welts can be aggravated with physical contact and grow larger.
Age: 75.0
Sex: F
Vaccine: FLU3
Symptoms: Mobility decreased, Musculoskeletal pain, Pain in extremity, Tendonitis
Clinical narrative: The pharmacist said "this muscle doesn't like this injection...you'll have some pain". I did have pain that night and it lasted "for over a month. But THEN noticed that I was having severe shoulder pain and from probably late Novemebr 2014, had difficulty lifting my right arm without pain. The pain is now such that beyond a certain level I can't lift my arm without pain that makes me drop anything I might be holding. Hard to put on a coat or fix my hair as that takes two hands. I continued taking IBU and putting warm compressed...to no avail. In the meantime I started physical therapy for a return of a neck injury. This clearly made my left arm worse. I saw my physician and she stopped PT and diagnosed my left as tendonitis. I am to continue IBU and hot compresses and return to her in a month (2 weeks from now,) My arm is no better nor worse, but the limits of range of motion are distressing and painful.  A few evenings ago I was with a group of womem who both were experiencing what I had, I asked, and yes, they both had that double dose flu shot.
Age: 52.0
Sex: F
Vaccine: MMR
Symptoms: Asthenia, Decreased appetite, Diarrhoea, Dry mouth
Clinical narrative: Diarrhea feeling weak, decrease appetite, and dry mouth.
Age: 71.0
Sex: F
Vaccine: PNC13
Symptoms: Discomfort, Disorientation, Erythema, Fatigue, Peripheral swelling
Clinical narrative: Pt noticed itching feeling and looked at arm.  It was hot & raised, about 2 inches wide and 4 inches in height.  That day she started to feel more fatigued, "feeling heavy" and more tired than normal.  On Thursday, 1/15 she also felt disoriented.  She came to show me the reaction on Fri 1/16 which was still raised, red and warm to touch. She was told to take some diphenhydramine if the itching bothered her.
Age: 71.0
Sex: F
Vaccine: PNC13
Symptoms: Pruritus, Skin warm
Clinical narrative: Pt noticed itching feeling and looked at arm.  It was hot & raised, about 2 inches wide and 4 inches in height.  That day she started to feel more fatigued, "feeling heavy" and more tired than normal.  On Thursday, 1/15 she also felt disoriented.  She came to show me the reaction on Fri 1/16 which was still raised, red and warm to touch. She was told to take some diphenhydramine if the itching bothered her.
Age: 37.0
Sex: F
Vaccine: FLUX
Symptoms: Angioedema, Dyspnoea, Laboratory test, Swelling
Clinical narrative: I did not allergy to any thing even eggs and after injection of flu shot start swelling all my body, angioedema, my face, both eyes, even once I could not able to breath. Up to now I visited by five providers, one of them was immunologist, and still I have symptoms and not recovered yet.
Age: 61.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Arrhythmia, Borrelia test negative, Cardiac imaging procedure normal, Echocardiogram normal, Electromyogram abnormal
Clinical narrative: Cardiac arrhythmia with palpitations.  Negative cardiac evaluation except frequent PVC's on Event Monitor.  Attributed to days autonomic likely from Guillain-Barre Syndrome. Poly neuropathy with numbness all extremities and face confirmed by NCV/EMG from post influenza vaccine GBS. High dose steroid therapy course failed to improve symptoms. Symptoms persist to this point without change.
Age: 61.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Laboratory test normal, Nerve conduction studies abnormal, Palpitations
Clinical narrative: Cardiac arrhythmia with palpitations.  Negative cardiac evaluation except frequent PVC's on Event Monitor.  Attributed to days autonomic likely from Guillain-Barre Syndrome. Poly neuropathy with numbness all extremities and face confirmed by NCV/EMG from post influenza vaccine GBS. High dose steroid therapy course failed to improve symptoms. Symptoms persist to this point without change.
Age: 61.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Polyneuropathy, Scan myocardial perfusion normal, Thyroid function test normal, Ventricular extrasystoles
Clinical narrative: Cardiac arrhythmia with palpitations.  Negative cardiac evaluation except frequent PVC's on Event Monitor.  Attributed to days autonomic likely from Guillain-Barre Syndrome. Poly neuropathy with numbness all extremities and face confirmed by NCV/EMG from post influenza vaccine GBS. High dose steroid therapy course failed to improve symptoms. Symptoms persist to this point without change.
Age: 61.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Arrhythmia, Borrelia test negative, Cardiac imaging procedure abnormal, Echocardiogram normal, Electromyogram abnormal
Clinical narrative: Cardiac arrhythmia with palpitations.  Negative cardiac evaluation except frequent PVC's on Event Monitor.  Attributed to days autonomic likely from Guillain-Barre Syndrome. Poly neuropathy with numbness all extremities and face confirmed by NCV/EMG from post influenza vaccine GBS. High dose steroid therapy course failed to improve symptoms. Symptoms persist to this point without change.
Age: 61.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Nerve conduction studies abnormal, Palpitations, Polyneuropathy
Clinical narrative: Cardiac arrhythmia with palpitations.  Negative cardiac evaluation except frequent PVC's on Event Monitor.  Attributed to days autonomic likely from Guillain-Barre Syndrome. Poly neuropathy with numbness all extremities and face confirmed by NCV/EMG from post influenza vaccine GBS. High dose steroid therapy course failed to improve symptoms. Symptoms persist to this point without change.
Age: 61.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Scan myocardial perfusion normal, Thyroid function test normal, Ventricular extrasystoles
Clinical narrative: Cardiac arrhythmia with palpitations.  Negative cardiac evaluation except frequent PVC's on Event Monitor.  Attributed to days autonomic likely from Guillain-Barre Syndrome. Poly neuropathy with numbness all extremities and face confirmed by NCV/EMG from post influenza vaccine GBS. High dose steroid therapy course failed to improve symptoms. Symptoms persist to this point without change.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Body temperature increased, Decreased appetite, Headache, Malaise, Rash
Clinical narrative: Patient reports last week he had elevated temperature, headache, malaise, and decreased appetite. On 24 January 2014, the patients girlfriend noted small bumps over his back and anterior collar bone area that do not itch. Patient reports the small bumps on his lower legs and ankles do itch.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Rash pruritic
Clinical narrative: Patient reports last week he had elevated temperature, headache, malaise, and decreased appetite. On 24 January 2014, the patients girlfriend noted small bumps over his back and anterior collar bone area that do not itch. Patient reports the small bumps on his lower legs and ankles do itch.
Age: 68.0
Sex: M
Vaccine: FLU3, PNC13
Symptoms: Asthenia, Chills, Diarrhoea, Pyrexia
Clinical narrative: About 2 hours after immunization, patient had high fever 101+, diarrhea, chills, weak. Lasted about 2 days. Reports he lost 8 pounds.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On 17-DEC-2014, the patient was vaccinated with an improperly stored GARDASIL (lot # K004204, expiry date 12-JAN-2017) (dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a nurse refers to unspecified patients. No current or historical conditions were reported. On 29-SEP-2014 the patients were vaccinated with ZOSTAVAX (lot# K008880, expiration date 09-SEP-2015), dose, route unspecified which were improperly exposed to -4.9C for 109 hours. No adverse experience had been observed or reported. This is one of several reports received from same source. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unkonwn age and gender. On 23-DEC-2014 the patient was vaccinated with an improperly stored VAQTA (lot # J000366, expiry date 22-AUG-2015) dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On 25-NOV-2014 the patient was vaccinated with an improperly stored VAQTA (lot # J000366, expiry date 22-AUG-2015) (dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On 26-NOV-2014 the patient was vaccinated with an improperly stored VAQTA (lot # J000366, expiry date 22-AUG-2015) (dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On 15-DEC-2014 the patient was vaccinated with an improperly stored VAQTA (lot # J000366, expiry date 22-AUG-2015) (dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On 20-DEC-2014 the patient was vaccinated with an improperly stored VAQTA (lot # 59N59, expiry date 05-SEP-2016) (dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On 05-JAN-2015, the patient was vaccinated with an improperly stored GARDASIL (lot # K004204, expiry date 12-JAN-2017) (dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On 16-DEC-2014 the patient was vaccinated with an improperly stored GARDASIL (lot # K004204, expiry date 12-JAN-2017) (dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of the several reports received from reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On 06-JAN-2015, the patient was vaccinated with an improperly stored GARDASIL (lot # K004204, expiry date 12-JAN-2017) (dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On 15-DEC-2014, the patient was vaccinated with an improperly stored GARDASIL (lot # K004204, expiry date 12-JAN-2017) (dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Rash, Rash erythematous, Rash vesicular
Clinical narrative: Pt. developed itching, redness/pinkish spots on arms and legs pt thought similar to chicken pox. Pt self treated with lotion and itch cream which seemed to control itching. Pt did not report to doctor as pt. thought it was just a reaction. Pt seems OK one month afterward.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site vesicles
Clinical narrative: Patient came into store today and showed us her reaction to the vaccine. At the injection site it is red, raised, and has a blister in the middle. Pt is calling MD in the morning to be evaluated.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a Licensed Practical Nurse refers to an unknown amount of patients of unknown age. Medical history and current condition of the patients were not reported. The nurse stated that the unknown amount of patients were vaccinated with improperly stored GARDASIL (lot # K006117, expiry date 14-JAN-2017), (dose, route unspecified) from September 2014 till January 2015. No adverse effects reported. No product quality complaint (PQC) reported. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site streaking, Injection site swelling
Clinical narrative: This spontaneous report as received from a 60 year old female patient refers to herself who was an emergency nurse formerly. The patient's concurrent condition included high blood pressure, high cholesterol, high triglycerides and insomnia. The patient was allergic to PHENERGAN (reported as "finerigan") and COMPAZINE (reported as "composene"). On 07-JAN-2015 the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiration date and dose were unknown, one time vaccine) subcutaneous. Concomitant therapies included LOVAZA, ZOCOR, atenolol, cholecalciferol, TRICOR, AMBIEN (reported as Anbian), SYSTANE, Prenatal vitamin. On 07-JAN-2015, the patient had an "about 3 1/2 by 1 inch dependent streak on her left posterior injection arm, at the injection site". The patient further stated that it was raised, red, itchy and "sensitive to the touch". On 08-JAN-2015, the patient stated that the vaccine injection site still had the "about 3.5 inch distal streak that looked like a burn from a curling iron but not like a blister or chicken pox like she had had as a child". The patient had sought for unspecified medical attention. The patient was not given treatment for the events at the time of report. The outcome of the events "about 3.5 inch distal streak that looks like a burn from a curling iron" was not recovered at the time of report. The outcome of the events "it was raised, red, itchy and sensitive to touch at the injection site" was unknown at the time of report. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Anxiety, Hypoaesthesia, Limb discomfort, Muscular weakness, Paraesthesia
Clinical narrative: Information has been received from a medical assistant refers to a 13 year old female patient with wheezing. The patient had no drug reactions/allergies. On 12-JAN-2015 the patient was vaccinated with the first dose of GARDASIL (lot # K006960, expiration date 19-FEB-2017, 0.5ml, intramuscular in the left arm). Concomitant therapies included PROAIR. On 13-JAN-2015 the patient called office complaining of numbness and tingling of the left arm and feeling anxious. The patient was prescribed BENADRYL as treatment. The patient called back later on 13-JAN-2015 to report she was experiencing numbness and tingling of her whole body, especially her legs and feet. On 14-JAN-2015, the numbness and tingling resolved but the patient had developed a "heaviness and weakness" of her legs. The heaviness and weakness of her legs resolved on 16-JAN-2015. No Lab diagnostics studies were performed. No intervention was given to prevent serious criteria. The medical assistant added that the patient would not be administered additional doses of GARDASIL. The outcome of the event feeling anxious was not reported. Additional information has been requested.
Age: 84.0
Sex: M
Vaccine: VARZOS
Symptoms: Lip swelling, Pruritus
Clinical narrative: Pt reported that he experienced swelling of the lips on the day that he received vaccination 11/21/14 but did not report at that time. He has again experienced swollen lips after that and now in addition itching at night. Rxn reported on 1/23/15.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Herpes zoster, Peripheral swelling
Clinical narrative: Grapefruit size reaction/swelling on back of arm, red, pt states she had shingles Kw/in 24 hours (tiny spots). She suffers from recurring shingles and her MD wanted to see if vaccine would help.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On 24-NOV-2014, the patient was vaccinated with an improperly stored GARDASIL (lot # H020901, expiry date 05-JUL-2015) (dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On 05-DEC-2014, the patient was vaccinated with an improperly stored GARDASIL (lot # K004204, expiry date 12-JAN-2017) (dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On 04-DEC-2014, the patient was vaccinated with an improperly stored GARDASIL (lot # K004204, expiry date 12-JAN-2017) (dosing regimen, route and frequency unknown). No concomitant medications were reported. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a nurse refers to unspecified patients. No current or historical conditions were reported. On 29-SEP-2014 the patients were vaccinated with VARIVAX (Merck) (lot # J001181, expiration date 31-JAN-2015), dose, route unspecified which were improperly exposed to -4.9C for 109 hours. No adverse experience has been observed or reported. This is one of several reported received from same source. Additional information has been requested.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Induration, Injection site pruritus, Skin warm
Clinical narrative: Initial report received from healthcare professional on 27 September 2013. A 50-year-old female patient received FLUZONE INTRADERMAL (lot number UT4720AB and expiration date unknown) intradermal on left arm (dose number not reported) on 17 September 2013. The patient had no medical history. The concomitant medication was not reported. On 18 September 2013, the patient developed an area of induration that measured approximately 3"x2" that was reddened and warm to touch. The patient experienced site was mildly itchy at bedtime. Laboratory investigation and corrective treatment were not reported. As of this report, the patient had recovered from the events. Documents held by sender: none.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Pain, Pain in extremity
Clinical narrative: Initial report received from healthcare professional on 24 January 2014. A 32-year-old female patient, whose medical history and concomitant medications were not reported, had received intradermal dose of FLUZONE ID, batch number: UT4720AA having expiry date 3 April 2014 (dose number was not reported) in left deltoid on 03 October 2013. It was reported that on 24 January 2014, 113 day after receiving FLUZONE ID vaccine, the patient experienced pain while lifting her left arm. Patient stated this has been since November and this is the first and only time she ever mentioned anything about this. Patient has not self-treated nor has she required physician evaluation and/or any prescribed medical treatment. Laboratory investigations were not reported. At the time of this report, the outcome was unknown. Documents held by sender: none. Follow-up information received from healthcare professional on 31 March 2014. It was reported that, the patient still had some difficulty during lifting her arm. The patient is allergic to penicillin. At the time of this report, the outcome was not recovered.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site discolouration, Injection site erythema
Clinical narrative: Initial report received from healthcare professional on 26 June 2014. A '62-year-old female patient', whose medical history and concomitant medication were not reported, had received a intramuscular dose of FLUZONE Intradermal in to the left upper arm on 05 February 2014 at 01:30 PM. (Lot number UT4725BA, expiration date, route and dose number was not reported), and the subject had injection site dark reddish to blackish, the size of dime even after four month. The laboratory details and corrective treatment were not reported. The outcome of the event was not recovered at the time of report. List of documents held by sender: none.
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Anal pap smear abnormal, Anogenital warts, Blood potassium, Blood test, Cervical dysplasia
Clinical narrative: Abnormal Pap- LISL, then 8/16/2010 IBS, 10/15/2010 Migraines with visual, 11/19/2010 varicose veins with Greater Saphenous vein litigation, 11/10/2011 Genital and anal HSVI and HPV with Anal condoloma removal surgery (ongoing), 9/17/2012 Interstitial Cystitis Onset (ongoing), 07/2013 Fibromyaliga Dx (ongoing).
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Culture urine, Cystitis interstitial, Cystoscopy abnormal, Fibromyalgia, Genital herpes
Clinical narrative: Abnormal Pap- LISL, then 8/16/2010 IBS, 10/15/2010 Migraines with visual, 11/19/2010 varicose veins with Greater Saphenous vein litigation, 11/10/2011 Genital and anal HSVI and HPV with Anal condoloma removal surgery (ongoing), 9/17/2012 Interstitial Cystitis Onset (ongoing), 07/2013 Fibromyaliga Dx (ongoing).
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Genital herpes simplex, Human papilloma virus test positive, Irritable bowel syndrome, Migraine with aura, Nuclear magnetic resonance imaging
Clinical narrative: Abnormal Pap- LISL, then 8/16/2010 IBS, 10/15/2010 Migraines with visual, 11/19/2010 varicose veins with Greater Saphenous vein litigation, 11/10/2011 Genital and anal HSVI and HPV with Anal condoloma removal surgery (ongoing), 9/17/2012 Interstitial Cystitis Onset (ongoing), 07/2013 Fibromyaliga Dx (ongoing).
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Papilloma viral infection, Smear cervix abnormal, Surgery, Ultrasound scan, Varicose vein
Clinical narrative: Abnormal Pap- LISL, then 8/16/2010 IBS, 10/15/2010 Migraines with visual, 11/19/2010 varicose veins with Greater Saphenous vein litigation, 11/10/2011 Genital and anal HSVI and HPV with Anal condoloma removal surgery (ongoing), 9/17/2012 Interstitial Cystitis Onset (ongoing), 07/2013 Fibromyaliga Dx (ongoing).
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Venous ligation
Clinical narrative: Abnormal Pap- LISL, then 8/16/2010 IBS, 10/15/2010 Migraines with visual, 11/19/2010 varicose veins with Greater Saphenous vein litigation, 11/10/2011 Genital and anal HSVI and HPV with Anal condoloma removal surgery (ongoing), 9/17/2012 Interstitial Cystitis Onset (ongoing), 07/2013 Fibromyaliga Dx (ongoing).
Age: 72.0
Sex: M
Vaccine: PNC13
Symptoms: Musculoskeletal pain, Myalgia, Pain
Clinical narrative: Muscle and movement pain in shoulder of injection.
Age: 64.0
Sex: M
Vaccine: FLU3, VARZOS
Symptoms: Incorrect route of drug administration, No adverse event
Clinical narrative: Case number PHEH2013US022145 is an initial spontaneous report received from a pharmacist on 21 Oct 2013 with a follow up information received from a pharmacist on 18 Nov 2013. This report refers to a 64-years-old male patient. His medical history included smoking and concomitant medications were not reported. He was vaccinated with FLUVIRIN (batch number: 130940) at a dose of 0.5 ml subcutaneously on 21 Oct 2013. He also received ZOSTAVAX (other manufacturer, batch number: not reported) on the same day. No adverse reactions were reported following the maladministration. Follow up information received from a pharmacist on 18 Nov 2013: Patient demographics (date of birth, age and initials), medical history, concomitant vaccination and dose of FLUVIRIN updated.
Age: 49.0
Sex: M
Vaccine: HEP
Symptoms: Chills, Diarrhoea, Hyperhidrosis, Injection site erythema, Injection site pruritus
Clinical narrative: Employee states site started itching Saturday, 1 day after getting   varicella vaccination. States she has been getting spells of chills and sweats, diarrhea since Saturday. Redness and swelling at injection site. No fever today. She has been putting hydrocortisone on injection site.
Age: 49.0
Sex: M
Vaccine: HEP
Symptoms: Injection site swelling
Clinical narrative: Employee states site started itching Saturday, 1 day after getting   varicella vaccination. States she has been getting spells of chills and sweats, diarrhea since Saturday. Redness and swelling at injection site. No fever today. She has been putting hydrocortisone on injection site.
Age: 6.0
Sex: M
Vaccine: DTAP, IPV, MMRV, PNC13
Symptoms: Affect lability, Antibody test positive, Anxiety, Attention deficit/hyperactivity disorder, Autism
Clinical narrative: Extreme emotional meltdowns, self harm, suicidal thoughts. Later (May 2013) diagnosed as PANDAS, ADD (diagnosed May 2013) with some autistic features, Anxiety, OCD. Mercury toxicity (blood test; permeable gut resulting in multiple nutritional deficiencies. New teeth coming in had no enamel after perfect teeth up to this point. Documented, objective regression in fine motor and math.
Age: 6.0
Sex: M
Vaccine: DTAP, IPV, MMRV, PNC13
Symptoms: Blood heavy metal increased, Blood test, Emotional distress, Gastrointestinal disorder, Intentional self-injury
Clinical narrative: Extreme emotional meltdowns, self harm, suicidal thoughts. Later (May 2013) diagnosed as PANDAS, ADD (diagnosed May 2013) with some autistic features, Anxiety, OCD. Mercury toxicity (blood test; permeable gut resulting in multiple nutritional deficiencies. New teeth coming in had no enamel after perfect teeth up to this point. Documented, objective regression in fine motor and math.